AIM ImmunoTech, Inc. (AIM)
1.45
0.00 (0.00%)
USD |
NYAM |
Dec 11, 16:00
1.40
-0.05
(-3.45%)
Pre-Market: 09:03
AIM ImmunoTech Research and Development Expense (TTM): 3.826M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics, Inc. | 61.22M |
| Protalix Biotherapeutics, Inc. | 18.06M |
| Electromed, Inc. | 1.071M |
| Xtant Medical Holdings, Inc. | 2.165M |
| Armata Pharmaceuticals, Inc. | 26.10M |